ARCHIVES

Genentech’s Ferrara Selected for GM Award.

This article is from The Cancer Letter archive.

Vol. 32 No. 24 | June 23, 2006

Download PDF Visit The Full Archive

Related Articles

Virus Cancer Program Report On Scientific Activities

August 1, 1975

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

NCI’s Weinstein Said He Never Pressured Researcher

November 3, 1995

Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.

October 19, 2001

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996